This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Eletriptan worth it for migraine. Pharmacoecon. Outcomes News 349, 9 (2002). https://doi.org/10.1007/BF03278669
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03278669